International Assets Investment Management LLC Invests $185,000 in Bausch Health Companies Inc. (NYSE:BHC)

International Assets Investment Management LLC purchased a new position in shares of Bausch Health Companies Inc. (NYSE:BHC) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 23,058 shares of the company’s stock, valued at approximately $185,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Ausdal Financial Partners Inc. acquired a new stake in shares of Bausch Health Companies during the 3rd quarter worth approximately $86,000. Jump Financial LLC acquired a new stake in Bausch Health Companies in the 3rd quarter valued at approximately $92,000. Mitsubishi UFJ Trust & Banking Corp acquired a new stake in Bausch Health Companies in the 3rd quarter valued at approximately $103,000. Pathstone Family Office LLC acquired a new stake in Bausch Health Companies in the 3rd quarter valued at approximately $169,000. Finally, Park Avenue Securities LLC acquired a new stake in Bausch Health Companies in the 3rd quarter valued at approximately $169,000. Institutional investors and hedge funds own 78.65% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on BHC. Royal Bank of Canada dropped their target price on shares of Bausch Health Companies from $12.00 to $11.00 and set a “sector perform” rating for the company in a report on Tuesday, April 23rd. Jefferies Financial Group dropped their target price on shares of Bausch Health Companies from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, February 20th. Finally, StockNews.com upgraded shares of Bausch Health Companies from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th.

Bausch Health Companies Stock Up 1.0 %

NYSE:BHC opened at $8.71 on Monday. The company has a fifty day simple moving average of $9.30 and a two-hundred day simple moving average of $8.18. The company has a market cap of $3.18 billion, a price-to-earnings ratio of -5.38 and a beta of 0.85. Bausch Health Companies Inc. has a 52 week low of $5.57 and a 52 week high of $11.46.

Bausch Health Companies (NYSE:BHC) last posted its quarterly earnings results on Thursday, February 22nd. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.01 by $0.14. The business had revenue of $2.41 billion during the quarter, compared to the consensus estimate of $2.29 billion. Bausch Health Companies had a negative net margin of 6.76% and a positive return on equity of 5,147.48%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.02 earnings per share. On average, analysts expect that Bausch Health Companies Inc. will post 3.95 EPS for the current year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.